Indeed, the TDX pool only included 25 of the 66 SARS-CoV-2 CD8+ T epitopes that were predicted to be cross-reactive with tetanus-diphtheria antigens (Supplementary Dataset 2). This evidence concerns the gene CD8A and diphtheria.